FIELD: medicine. SUBSTANCE: this method prescribes administering finely divided silica as enteroabsorbent to be taken in dose of 100 to 110 mg/kg from the very start of disease. Disclosed method further prescribes using this enteroabsorbent as aqueous suspension in periods between food intakes. EFFECT: shorter rehabilitation period and lower rate of complications.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT OF THROMBOSES AND THROMBOEMBOLISMS | 1991 |
|
RU2018311C1 |
| METHOD OF CURING ACUTE MYOCARDIAL INFARCTION AND UNSTABLE STENOCARDIA | 1991 |
|
RU2016569C1 |
| SUBSTANCE HAVING ADAPTATION PROMOTING ACTIVITY | 1992 |
|
RU2038085C1 |
| METHOD OF NONSTABLE STENOCARDIA TREATMENT | 1992 |
|
RU2072842C1 |
| METHOD OF TREATMENT OF LUNG AND PLEURA PURULENT DISEASES | 1992 |
|
RU2064799C1 |
| METHOD FOR TREATMENT OF WOUNDS | 1990 |
|
RU2008005C1 |
| METHOD FOR DETECTING INDICATION FOR SURGICAL MYOCARDIAL REVASCULARIZATION IN PATIENTS WITH ISCHEMIC CARDIAC DISEASE (ICD) AT ACCOMPANYING PATHOLOGY | 2002 |
|
RU2286091C2 |
| METHOD FOR TREATING VENTRICULAR EXTRASYSTOLE THE CASES OF MYOCARDIAL INFARCTION | 2000 |
|
RU2197241C2 |
| METHOD FOR MULTIVARIATE PREDICTION OF CHRONIC HEART FAILURE AFTER PRIMARY MYOCARDIAL INFARCTION WITH ST SEGMENT ELEVATION DURING 48-WEEK FOLLOW-UP | 2021 |
|
RU2754798C1 |
| METHOD FOR PROGNOSTICATING COURSE OF HOSPITAL TREATMENT PERIOD FOR PATIENT AFFECTED WITH MYOCARDIAL INFARCTION | 1993 |
|
RU2078535C1 |
